HAMBURG (dpa-AFX Broker) - The private bank Berenberg has left its rating for Fresenius Medical Care (FMC) at "Buy" with a target price of 47 euros ahead of the first quarter figures. The dialysis specialist should have performed better in terms of profitability compared to the particularly cautious management forecast, analyst Victoria Lambert wrote in a study published on Monday. The company is likely to have benefited in part from price increases and cost reductions./mis/ajx

Publication of the original study: 19.04.2024 / 16:20 / GMT

First disclosure of the original study: Date not specified in study / Time not specified in study / Time zone not specified in study

-----------------------

dpa-AFX Broker - the Trader News from dpa-AFX

-----------------------